Inventor
FELDHAUS MICHAEL
US30 patents
⚠️ This page may combine multiple inventors who share the name “FELDHAUS MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ADIMAB LLC
8 patentsUS10189894B2Jan 29, 2019
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC6 citations84
US10196635B2Feb 5, 2019
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC4 citations73
US12018403B2Jun 25, 2024
Antibody libraries
ADIMAB LLC1 citations72
US10889811B2Jan 12, 2021
Antibody libraries
ADIMAB LLC1 citations72
US10138478B2Nov 27, 2018
Antibody libraries
ADIMAB LLC3 citations72
US11008383B2May 18, 2021
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC1 citations62
US11008568B2May 18, 2021
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC1 citations62
US12529164B2Jan 20, 2026
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC0 citations52
MERRIMACK PHARMACEUTICALS INC
6 patentsUS7846440B2Dec 7, 2010
Antibodies against ErbB3 and uses thereof
MERRIMACK PHARMACEUTICALS INC92 citations98
US9487588B2Nov 8, 2016
Antibodies against the ectodomain of ERBB3 and uses thereof
MERRIMACK PHARMACEUTICALS INC4 citations83
US9226964B2Jan 5, 2016
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
MERRIMACK PHARMACEUTICALS INC9 citations82
US10072299B2Sep 11, 2018
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
MERRIMACK PHARMACEUTICALS INC0 citations49
US9902999B2Feb 27, 2018
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
MERRIMACK PHARMACEUTICALS INC0 citations49
US9885087B2Feb 6, 2018
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
MERRIMACK PHARMACEUTICALS INC0 citations49
SEAGEN INC
4 patentsUS11078291B2Aug 3, 2021
BCMA antibodies and use of same to treat cancer and immunological disorders
SEAGEN INC8 citations82
US11767365B2Sep 26, 2023
BCMA antibodies and use of same to treat cancer and immunological disorders
SEAGEN INC1 citations61
US12071480B2Aug 27, 2024
CD47 antibodies and uses thereof for treating cancer
SEAGEN INC0 citations53
US11180552B2Nov 23, 2021
CD47 antibodies and uses thereof for treating cancer
SEAGEN INC0 citations53
VASQUEZ MAXIMILIANO
3 patentsUS8691730B2Apr 8, 2014
Rationally designed, synthetic antibody libraries and uses therefor
VASQUEZ MAXIMILIANO73 citations97
US8877688B2Nov 4, 2014
Rationally designed, synthetic antibody libraries and uses therefor
VASQUEZ MAXIMILIANO27 citations92
US9354228B2May 31, 2016
Antibody libraries
VASQUEZ MAXIMILIANO18 citations91
GENENTECH INC
3 patentsUS11008403B2May 18, 2021
Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use
GENENTECH INC3 citations71
US11746160B2Sep 5, 2023
Antibodies against BACE1 and use thereof for neural disease immunotherapy
GENENTECH INC0 citations61
US10882920B2Jan 5, 2021
Antibodies against BACE1 and use thereof for neural disease immunotherapy
GENENTECH INC0 citations61